Biopharmaceuticals
- Market
AstraZeneca 1Q Rev $11.39B
By Cecilia Butini AstraZeneca PLC said Friday that it expects sales of its Covid-19 medicines, including its vaccine, to decline…
Read More » - Market
How Gilead is positioning Veklury against COVID-19 antivirals like Paxlovid
Gilead Sciences Inc. GILD, -0.05% has steadily expanded the use of Veklury while much of the nation’s attention has shifted…
Read More » - Market
FDA approves Pfizer’s COVID-19 shot, making it the first vaccine to receive ‘full’ approval in the U.S.
The U.S. formally approved BioNTech and Pfizer’s COVID-19 vaccine in a move that could sway some of the unvaccinated to…
Read More »
